Zi Shen Huo Luo Formula Enhances the Therapeutic Effects of Angiotensin-Converting Enzyme Inhibitors on Hypertensive Left Ventricular Hypertrophy by Interfering With Aldosterone Breakthrough and Affecting Caveolin-1/Mineralocorticoid Receptor Colocalization and Downstream Extracellular Signal-Regulated Kinase Signaling
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2020.00383
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 3, 2020
Authors
Publisher
Frontiers Media SA